2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA.

2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA.
复制标题

第二次PEGS癌症抗体年度研讨会:2012年4月30日至2012年5月1日,美国波士顿。

DOI:
10.4161/mabs.21521
复制
发表时间:
2012-09
期刊:
影响因子:
5.3
通讯作者:
Beck A
Beck A
中科院分区:
医学2区
文献类型:
--
作者:
Ho M;Royston I;Beck A

文献摘要

参考文献

被引文献

相似文献

The 2nd Annual Antibodies for Cancer Therapy symposium, organized again by Cambridge Healthtech Institute as part of the Protein Engineering Summit, was held in Boston, USA from April 30th to May 1st, 2012. Since the approval of the first cancer antibody therapeutic, rituximab, fifteen years ago, eleven have been approved for cancer therapy, although one, gemtuzumab ozogamicin, was withdrawn from the market.  The first day of the symposium started with a historical review of early work for lymphomas and leukemias and the evolution from murine to human antibodies. The symposium discussed the current status and future perspectives of therapeutic antibodies in the biology of immunoglobulin, emerging research on biosimilars and biobetters, and engineering bispecific antibodies and antibody-drug conjugates. The tumor penetration session was focused on the understanding of antibody therapy using ex vivo tumor spheroids and the development of novel agents targeting epithelial junctions in solid tumors. The second day of the symposium discussed the development of new generation recombinant immunotoxins with low immunogenicity, construction of chimeric antigen receptors, and the proof-of-concept of ‘photoimmunotherapy’. The preclinical and clinical session presented antibodies targeting Notch signaling and chemokine receptors.  Finally, the symposium discussed emerging technologies and platforms for therapeutic antibody discovery.
DOI: 10.1002/ijc.25557
发表时间: 2011-05-01
影响因子: 6.4
作者:
Ho, Mitchell;Feng, Mingqian;Fisher, Robert J.;Rader, Christoph;Pastan, Ira
通讯作者: Pastan, Ira
DOI: 10.1158/0008-5472.can-11-2009
发表时间: 2011-11-15
期刊: Cancer research
影响因子: 11.2
作者:
Beyer I;van Rensburg R;Strauss R;Li Z;Wang H;Persson J;Yumul R;Feng Q;Song H;Bartek J;Fender P;Lieber A
通讯作者: Lieber A
DOI: 10.1073/pnas.0800800105
发表时间: 2008-08-26
影响因子: 11.1
作者:
Hofer, Thomas;Thomas, Joshua D.;Rader, Christoph
通讯作者: Rader, Christoph
DOI: 10.1038/nri2747
发表时间: 2010-05-01
影响因子: 100.3
作者:
Beck, Alain;Wurch, Thierry;Corvaia, Nathalie
通讯作者: Corvaia, Nathalie
DOI: 10.1158/0008-5472.can-10-2817
发表时间: 2011-03-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Fischer, Marcus;Yen, Wan-Ching;Hoey, Timothy
通讯作者: Hoey, Timothy